These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33634752)

  • 21. Smart triblock dendritic unimolecular micelles as pioneering nanomaterials: Advancement pertaining to architecture and biomedical applications.
    Tambe P; Kumar P; Paknikar KM; Gajbhiye V
    J Control Release; 2019 Apr; 299():64-89. PubMed ID: 30797002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Overview of Polymeric Nanoparticles-Based Drug Delivery System in Cancer Treatment.
    Dristant U; Mukherjee K; Saha S; Maity D
    Technol Cancer Res Treat; 2023; 22():15330338231152083. PubMed ID: 36718541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticles-encapsulated polymeric microneedles for transdermal drug delivery.
    Chen M; Quan G; Sun Y; Yang D; Pan X; Wu C
    J Control Release; 2020 Sep; 325():163-175. PubMed ID: 32629134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered Polymer-Based Nanomaterials for Diagnostic, Therapeutic and Theranostic Applications.
    Parisi OI; Scrivano L; Sinicropi MS; Picci N; Puoci F
    Mini Rev Med Chem; 2016; 16(9):754-61. PubMed ID: 26156541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advancements in two-dimensional nanomaterials for drug delivery.
    Mei X; Hu T; Wang Y; Weng X; Liang R; Wei M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1596. PubMed ID: 31650709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
    Mohammed L; Ragab D; Gomaa H
    Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentials and challenges of active targeting at the tumor cells by engineered polymeric nanoparticles.
    Mukherjee B; Satapathy BS; Mondal L; Dey NS; Maji R
    Curr Pharm Biotechnol; 2013; 14(15):1250-63. PubMed ID: 24910012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.
    Ajorlou E; Khosroushahi AY
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):251-265. PubMed ID: 27744564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.
    Gupta M; Agrawal GP; Vyas SP
    Curr Mol Med; 2013 Jan; 13(1):179-204. PubMed ID: 22834834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of Magnetic Nanoplatforms for Cancer Theranostics.
    Jiao W; Zhang T; Peng M; Yi J; He Y; Fan H
    Biosensors (Basel); 2022 Jan; 12(1):. PubMed ID: 35049666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationally-designed Chitosan-based Polymeric Nanomaterials According to Intrinsic Characteristics for Cancer Therapy and Theranostics: A Review.
    Yu F; Zhu Y; Shang X; Yuan H; Hu F
    Curr Med Chem; 2023; 30(12):1368-1385. PubMed ID: 35726412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabrication of nanoparticles within polymeric pores for controlled release of drug.
    Asif M; Arayne MS; Sultana N; Hussain F
    Pak J Pharm Sci; 2006 Jan; 19(1):73-84. PubMed ID: 16632458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-chain polymer nanoparticles in controlled drug delivery and targeted imaging.
    Kröger APP; Paulusse JMJ
    J Control Release; 2018 Sep; 286():326-347. PubMed ID: 30077737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemo-drug Controlled-release Strategies of Nanocarrier in the Development of Cancer Therapeutics.
    Liu Y; Ou H; Pei X; Jiang B; Ma Y; Liu N; Wen C; Peng C; Hu X
    Curr Med Chem; 2021; 28(31):6307-6322. PubMed ID: 32503398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature.
    Karabasz A; Bzowska M; Szczepanowicz K
    Int J Nanomedicine; 2020; 15():8673-8696. PubMed ID: 33192061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
    Dilnawaz F
    Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymeric networks for controlled release of drugs: a patent review.
    du Toit LC; Choonara YE; Kumar P; Pillay V
    Expert Opin Ther Pat; 2016 Jun; 26(6):703-17. PubMed ID: 27079971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible stimuli-responsive nanomaterials with on-off switching ability for biomedical applications.
    Alejo T; Uson L; Arruebo M
    J Control Release; 2019 Nov; 314():162-176. PubMed ID: 31644937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.